🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 10 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/01/2017 | 64,22 | 64,60 | 63,68 | 64,51 | +1,25% | 1,43% | 612.827 |
| 24/01/2017 | 64,26 | 64,33 | 63,48 | 63,71 | -0,82% | 1,32% | 465.351 |
| 23/01/2017 | 64,56 | 64,56 | 63,62 | 64,24 | -0,20% | 1,45% | 439.863 |
| 20/01/2017 | 63,80 | 65,57 | 63,66 | 64,37 | +1,90% | 3,00% | 635.750 |
| 19/01/2017 | 63,83 | 63,83 | 62,94 | 63,17 | -0,75% | 1,39% | 249.267 |
| 18/01/2017 | 63,32 | 63,71 | 62,78 | 63,65 | +0,56% | 1,47% | 467.275 |
| 17/01/2017 | 65,86 | 66,45 | 63,01 | 63,29 | -3,94% | 5,23% | 552.714 |
| 13/01/2017 | 66,43 | 67,37 | 65,62 | 65,89 | -0,74% | 2,64% | 302.807 |
| 12/01/2017 | 65,56 | 66,90 | 65,52 | 66,38 | +0,56% | 2,10% | 334.867 |
| 11/01/2017 | 68,34 | 68,34 | 65,27 | 66,01 | -3,25% | 4,50% | 447.237 |
| 10/01/2017 | 67,74 | 68,42 | 66,54 | 68,23 | +1,62% | 2,76% | 369.171 |
| 09/01/2017 | 67,57 | 67,92 | 66,51 | 67,14 | +0,02% | 2,10% | 566.340 |
| 06/01/2017 | 67,32 | 68,55 | 67,08 | 67,13 | -0,22% | 2,18% | 407.322 |
| 05/01/2017 | 66,27 | 67,56 | 66,11 | 67,28 | +2,08% | 2,18% | 489.396 |
| 04/01/2017 | 64,28 | 66,35 | 64,14 | 65,91 | +3,07% | 3,44% | 1.255.951 |
| 03/01/2017 | 64,01 | 65,10 | 63,56 | 63,94 | +0,88% | 2,42% | 409.246 |
| 30/12/2016 | 63,40 | 64,09 | 62,98 | 63,39 | +0,02% | 1,74% | 315.470 |
| 29/12/2016 | 63,36 | 64,34 | 63,01 | 63,37 | -0,22% | 2,10% | 241.091 |
| 28/12/2016 | 64,70 | 64,70 | 63,18 | 63,51 | -1,25% | 2,35% | 266.098 |
| 27/12/2016 | 65,02 | 65,86 | 63,81 | 64,32 | -0,53% | 3,16% | 349.775 |
| 23/12/2016 | 62,69 | 64,79 | 62,55 | 64,66 | +3,12% | 3,57% | 299.921 |
| 22/12/2016 | 65,27 | 65,87 | 62,16 | 62,70 | -3,44% | 5,68% | 857.445 |
| 21/12/2016 | 67,42 | 68,27 | 64,78 | 64,93 | -3,71% | 5,16% | 947.373 |
| 20/12/2016 | 66,79 | 67,64 | 66,00 | 67,44 | +1,77% | 2,46% | 283.090 |
| 19/12/2016 | 66,37 | 67,80 | 66,02 | 66,26 | +0,29% | 2,68% | 288.219 |
| 16/12/2016 | 67,16 | 68,28 | 65,90 | 66,07 | -2,02% | 3,55% | 767.677 |
| 15/12/2016 | 67,39 | 67,67 | 66,86 | 67,43 | +0,65% | 1,20% | 636.872 |
| 14/12/2016 | 67,06 | 67,55 | 66,44 | 66,99 | -0,27% | 1,66% | 482.182 |
| 13/12/2016 | 66,99 | 68,20 | 66,37 | 67,17 | +0,87% | 2,74% | 430.406 |
| 12/12/2016 | 65,02 | 66,63 | 64,73 | 66,59 | +2,17% | 2,93% | 392.575 |